Related Articles
An ovarian cancer model with positive ER: Reversion of ER antagonist resistance by Src blockade
Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levels
Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor α negative fulvestrant-resistant MCF-7 cells
The broad-spectrum metalloproteinase inhibitor BB-94 inhibits growth, HER3 and Erk activation in fulvestrant-resistant breast cancer cell lines
Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer